Norah L Henry
University of Michigan Rogel Cancer Center · University of Michigan · SWOG Cancer Research Network
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
17
all conditions, ClinicalTrials.gov
NIH grants tied to them
4
NIH RePORTER
Trial papers
52
PubMed author-name match
Trials
Studies that name Norah L Henry as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:08 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07443943 · A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS TrialUniversity of Michigan Rogel Cancer Center · recruiting · Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 · principal investigator
- Ph2NCT07158021 · Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS TrialUniversity of Michigan Rogel Cancer Center · recruiting · Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 · principal investigator
- Ph2NCT06617455 · Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT TrialUniversity of Michigan Rogel Cancer Center · terminated · Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 · principal investigator
- N/ANCT05700006 · Pilot Observational Study Examining the Effect of Endocrine Therapy on AgingUniversity of Michigan · completed · Breast Neoplasm Female, Arthralgia, Aging · principal investigator
- N/ANCT05568472 · Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN StudySWOG Cancer Research Network · active not recruiting · Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 · principal investigator
- Ph2NCT04754399 · Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated ArthralgiasUniversity of Michigan Rogel Cancer Center · completed · Arthralgia, Breast Cancer · principal investigator
- Early Ph1NCT02679586 · Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant ChemotherapyUniversity of Michigan Rogel Cancer Center · completed · Breast Cancer · principal investigator
- N/ANCT02495155 · Initial Assessment of an Internet-based Symptom Management Intervention in Early Stage Breast CancerUniversity of Michigan · completed · Breast Cancer, Fatigue, Insomnia · principal investigator
- N/ANCT02118636 · Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal SymptomsLynn Henry · completed · Breast Cancer, Arthralgia · principal investigator
- N/ANCT01983995 · Examining the Relationships Between Sleep, Fatigue, and Pain in Aromatase Inhibitor-treated PatientsUniversity of Michigan · completed · Breast Cancer · principal investigator
- N/ANCT01983982 · Effect of Chemotherapy on Pain Sensitivity and Patient-reported SymptomsUniversity of Michigan · completed · Breast Cancer, Chronic Pain · principal investigator
- Ph2NCT01921296 · Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer PatientsLynn Henry · terminated · Sleep Initiation and Maintenance Disorders, Pain · principal investigator
- N/ANCT01896050 · Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast CancerUniversity of Michigan Rogel Cancer Center · completed · Breast Cancer, Arthralgia, Obesity · principal investigator
- N/ANCT01814397 · Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer PatientsUniversity of Michigan Rogel Cancer Center · completed · Breast Cancer, Pain, Arthralgia · principal investigator
- N/ANCT01028352 · Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated PainUniversity of Michigan Rogel Cancer Center · completed · Breast Cancer · principal investigator
- N/ANCT00644683 · A Pilot Observational Study to Assess Changes in Biochemical Parameters of Ovarian Reserve With ChemotherapyLynn Henry · completed · Breast Cancer · principal investigator
- Ph2NCT00555477 · Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian FailureUniversity of Michigan Rogel Cancer Center · terminated · Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:08 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Active Symptom Monitoring and Endocrine Therapy Persistence in Young Women with Breast CancerR01CA266012 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · fiscal years 2022 to 2026 · $374,755 awarded in 2026Grant number is on one of their registry trials
- Community Outreach and EngagementP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · fiscal years 2026 · $423,533 awarded in 2026Same name and institution; not confirmed by an ID
- Inflammatory oxylipins and aromatase inhibitor toxicity in breast cancerR21CA251343 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · fiscal years 2021 · $427,833 awarded in 2021Same name and institution; not confirmed by an ID
- Predictors of Ovarian Function in Women Treated With Aromatase InhibitorsK07CA134747 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · fiscal years 2009 to 2012 · $172,584 awarded in 2012Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- SWOG NCORP Research BaseUG1CA189974 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI CHARLES D. BLANKE, DAWN HERSHMAN, Catherine M. Tangen · fiscal years 2014 to 2026Named on NCT05568472
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:08 UTC. The ranking covers the 200 most relevant of 52 PubMed records, and a shared surname and initials can bring in a namesake. All 52 on PubMed
- 345 citationsRCR 10.2
- Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer.J Clin Oncol · 2012314 citationsRCR 8.9
- 252 citationsRCR 10.5
- Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors.Breast Cancer Res Treat · 2008191 citationsRCR 4.7
- 113 citationsRCR 3.6
- 92 citationsRCR 3.3
- Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and age.Clin Pharmacol Ther · 201184 citationsRCR 2.5
- 81 citationsRCR 2.6
- 67 citationsRCR 1.5
- Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105.J Clin Oncol · 202067 citationsRCR 3.6